[go: up one dir, main page]

ES8608480A1 - Procedimiento perfeccionado para la fabricacion de derivadosde amidas organicas de lipidos nitrogenados - Google Patents

Procedimiento perfeccionado para la fabricacion de derivadosde amidas organicas de lipidos nitrogenados

Info

Publication number
ES8608480A1
ES8608480A1 ES545241A ES545241A ES8608480A1 ES 8608480 A1 ES8608480 A1 ES 8608480A1 ES 545241 A ES545241 A ES 545241A ES 545241 A ES545241 A ES 545241A ES 8608480 A1 ES8608480 A1 ES 8608480A1
Authority
ES
Spain
Prior art keywords
acid
reaction
nitrogen
amide compounds
compounds derived
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES545241A
Other languages
English (en)
Other versions
ES545241A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fidia SpA
Original Assignee
Fidia SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia SpA filed Critical Fidia SpA
Publication of ES8608480A1 publication Critical patent/ES8608480A1/es
Publication of ES545241A0 publication Critical patent/ES545241A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • C07D457/06—Lysergic acid amides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/10—Phosphatides, e.g. lecithin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/113—Esters of phosphoric acids with unsaturated acyclic alcohols
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/58—Pyridine rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/18—Acyclic radicals, substituted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Anesthesiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE DERIVADOS DE AMIDAS ORGANICAS DE LIPIDOS NITROGENADOS, DE FORMULA (I); EN LA QUE R1-CO- ES UN RESIDUO DE UN ACIDO ORGANICO QUE TIENE ACTIVIDAD FARMACOLOGICA O BIOLOGICA; R2 REPRESENTA HIDROGENO O UN RADICAL HIDROCARBONADO Y NR3 ES UN RESIDUO DERIVADO DE UN LIPIDO NITROGENADO. CONSISTE EN LA REACCION DE UN LIPIDO DE NITROGENO, DEL TIPO DE LOS FOSFOLIPIDOS O ESFINGOLIPIDOS, CON UN ANHIDRIDO MIXTO DE UN ACIDO CARBOXILICO DE FORMULA R1-COOH, OBTENIDO POR REACCION DE DICHO ACIDO CON ACIDO TRIFLUOROACETICO O CLORHIDRICO; O BIEN CON UN PRODUCTO DE ACILIMIDAZOL, OBTENIDO POR REACCION DEL ACIDO CARBOXILICO CON N,NK-CARBONILDIIMIDAZOL. ESTOS COMPUESTOS TIENEN APLICACIONES FARMACOLOGICAS POR SU ACTIVIDAD SOBRE LOS SISTEMAS NERVIOSOS CENTRAL Y PERIFERICO.
ES545241A 1981-08-03 1985-07-16 Procedimiento perfeccionado para la fabricacion de derivadosde amidas organicas de lipidos nitrogenados Expired ES8608480A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT49031/81A IT1171432B (it) 1981-08-03 1981-08-03 Amidi organiche derivate da lipidi azotati utilizzabili come farmaci

Publications (2)

Publication Number Publication Date
ES8608480A1 true ES8608480A1 (es) 1986-07-16
ES545241A0 ES545241A0 (es) 1986-07-16

Family

ID=11269438

Family Applications (3)

Application Number Title Priority Date Filing Date
ES514683A Expired ES8501735A1 (es) 1981-08-03 1982-08-03 Procedimiento para la fabricacion de amidas organicas derivadas de los lipidos nitrogenados.
ES533004A Expired ES8602616A1 (es) 1981-08-03 1982-08-03 Procedimiento perfeccionado para la fabricacion de amidas organicas derivadas de los lipidos nitrogenados.
ES545241A Expired ES8608480A1 (es) 1981-08-03 1985-07-16 Procedimiento perfeccionado para la fabricacion de derivadosde amidas organicas de lipidos nitrogenados

Family Applications Before (2)

Application Number Title Priority Date Filing Date
ES514683A Expired ES8501735A1 (es) 1981-08-03 1982-08-03 Procedimiento para la fabricacion de amidas organicas derivadas de los lipidos nitrogenados.
ES533004A Expired ES8602616A1 (es) 1981-08-03 1982-08-03 Procedimiento perfeccionado para la fabricacion de amidas organicas derivadas de los lipidos nitrogenados.

Country Status (21)

Country Link
US (3) US4757053A (es)
EP (1) EP0072286B2 (es)
JP (2) JPS5843942A (es)
KR (1) KR880000042B1 (es)
AT (1) ATE23165T1 (es)
AU (1) AU561811B2 (es)
DE (1) DE3273983D1 (es)
DK (1) DK159204C (es)
ES (3) ES8501735A1 (es)
FI (1) FI75829C (es)
GR (1) GR76234B (es)
HU (1) HU192771B (es)
IE (1) IE53644B1 (es)
IL (1) IL66454A0 (es)
IT (1) IT1171432B (es)
NO (1) NO161314C (es)
NZ (1) NZ201439A (es)
PL (1) PL141417B1 (es)
PT (1) PT75363B (es)
YU (3) YU43085B (es)
ZA (1) ZA825585B (es)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1171432B (it) * 1981-08-03 1987-06-10 Fidia Farmaceutici Amidi organiche derivate da lipidi azotati utilizzabili come farmaci
US5334583A (en) * 1982-07-23 1994-08-02 Ciba-Geigy Corp. Use of sugar derivatives for the prophylaxis and treatment of virus infections
US5189017A (en) * 1982-07-23 1993-02-23 Ciba-Geigy Corporation Use of sugar derivatives for the prophylaxis and treatment of virus infections
ATE45744T1 (de) * 1984-07-25 1989-09-15 Ciba Geigy Ag Phosphatidylverbindungen, verfahren zu ihrer herstellung und ihre verwendung.
US4885285A (en) * 1984-09-13 1989-12-05 Ciba-Geigy Corporation Phosphorus compounds, processes for their manufacture, and their use
LU85971A1 (fr) * 1985-06-25 1987-01-13 Oreal Nouveaux composes lipidiques amphiphiles, leur procede de preparation et leurs applications,notamnent en cosmetique et en dermopharmacie
US4873322A (en) * 1986-01-24 1989-10-10 Ciba-Geigy Corporation Saccharide derivatives and processes for their manufacture
US5434190A (en) * 1986-08-08 1995-07-18 Colgate-Palmolive Co. N-aryl and N-cycloalkyl neoalkanamide insect repellents
US5534553A (en) * 1987-06-12 1996-07-09 Hoerrmann; Wilhelm Drug containing fatty amino alcohols or derivatives thereof
DE3819870A1 (de) * 1987-06-12 1988-12-29 Hoerrmann Wilhelm Arzneimittel auf der basis von fett-amino-alkoholen
EP0299201A3 (de) * 1987-06-12 1990-08-22 Wilhelm Dr. Hoerrmann Fett-Aminoalkohol enthaltendes Arzneimittel
JP2588729B2 (ja) * 1987-10-05 1997-03-12 塩野義製薬株式会社 スフィンゴシン誘導体
IT1235162B (it) * 1988-12-02 1992-06-22 Fidia Farmaceutici Derivati di lisosfingolipidi
IT1238346B (it) * 1989-11-14 1993-07-13 Gangliosidi modificati e loro derivati funzionali.
US6362003B1 (en) 1992-02-24 2002-03-26 Coulter Corporation Hematological reference control composition containing leukocyte analogs, methods of making, and uses thereof
US6509192B1 (en) * 1992-02-24 2003-01-21 Coulter International Corp. Quality control method
DE4229877C2 (de) * 1992-09-04 1994-09-15 Max Delbrueck Centrum Phospho- bzw. Phosphono-(N-acyl)-serine und ihre Herstellung
US5346914A (en) * 1993-05-14 1994-09-13 Abbott Laboratories (4-alkoxypyran-4-yl) substituted arylalkylaryl-, arylalkenylaryl-, and arylalkynylarylurea inhibitors of 5-lipoxygenase
US5635536A (en) * 1994-12-07 1997-06-03 Pharmacia & Upjohn Aktiebolag Emulsion suitable for administering a sphingolipid
US6092636A (en) * 1997-08-07 2000-07-25 Nsk-Warner K.K. Oneway clutch
JP3874215B2 (ja) * 1997-08-07 2007-01-31 Ｎｓｋワーナー株式会社 ワンウェイクラッチおよびワンウェイクラッチ用外輪・ 保持器組立体
US6756504B2 (en) 2000-04-19 2004-06-29 Yissum Research Development Company Of The Hebrew University Of Jerusalem Sphingolipids
WO2001079152A1 (en) * 2000-04-19 2001-10-25 Yissum Research Development Company Of The Hebrew University Of Jerusalem Sphingolipids
US7217696B2 (en) 2002-02-28 2007-05-15 A & D Bioscience, Inc. Glycuronamides, glycosides and orthoester glycosides of fluoxetine, analogs and uses thereof
US20050107310A1 (en) * 2002-03-19 2005-05-19 Holick Michael F. Carboxylic acid glycuronides, glycosamides and glycosides of quinolones, penicillins, analogs, and uses thereof
WO2003086475A1 (en) * 2002-04-12 2003-10-23 A & D Bioscience, Inc. Conjugates comprising cancer cell specific ligands, a sugar and diagnostic agents, and uses thereof
JP4459629B2 (ja) 2002-04-12 2010-04-28 メルク エンド カムパニー インコーポレーテッド 二環式アミド
FR2839310A1 (fr) * 2002-05-03 2003-11-07 Pasteur Institut Nouveau procede de preparation d' alpha-glycosylceramides, nouveaux derives alpha-glycosylceramide et leurs applications
WO2003094842A2 (en) * 2002-05-07 2003-11-20 A & D Bioscience, Inc. Conjugates comprising central nervous system active drug
KR100496566B1 (ko) * 2002-06-11 2005-06-23 주식회사 포스코 탈황능이 향상된 무연탄을 이용한 용선용 탈황제
US20050215487A1 (en) * 2002-06-27 2005-09-29 Holick Michael F Conjugates comprising an nsaid and a sugar and uses thereof
CN107434814B (zh) * 2017-07-14 2019-05-03 中国科学院化学研究所 改性共轭聚合物及其制备方法和应用
JP2019161542A (ja) * 2018-03-15 2019-09-19 オンキヨー株式会社 振動板およびこれを用いたスピーカーユニット、ヘッドホン、並びにイヤホン、振動板の製造方法
KR102503769B1 (ko) * 2020-07-10 2023-02-27 솔루스바이오텍 주식회사 측쇄 지방산을 포함하는 신규한 스핑고지질과 그의 용도
CN115260091B (zh) * 2022-08-05 2025-06-06 深圳市迪克曼生物科技有限公司 含环状羧酸的神经酰胺类化合物及其制备方法和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH349592A (de) * 1956-06-06 1960-10-31 Ciba Geigy Verfahren zur Herstellung von ungesättigten, aliphatischen Aminodiolen
BE569345A (es) * 1957-07-12
GB1064293A (en) * 1963-07-15 1967-04-05 Bellon Labor Sa Roger Substituted 2-pyrrylketones
US3418325A (en) * 1965-12-23 1968-12-24 Bofors Ab Method of producing a product between meso-inositol and nicotinic acid
US3901893A (en) * 1970-05-18 1975-08-26 Richter Gedeon Vegyeszet New dihydro-lysergic acid derivative
US4064249A (en) * 1974-05-28 1977-12-20 Richter Gedeon Vegyeszeti Gyar Rt. Compounds with ergoline skeleton
HU169073B (es) * 1974-05-28 1976-09-28
DE2629135A1 (de) * 1976-06-29 1978-01-12 Nattermann A & Cie Neue phospholipid-derivate von prostaglandinen und verfahren zu ihrer herstellung
JPS565491A (en) * 1979-06-19 1981-01-20 Nattermann A & Cie Nnoleyl derivative of phosphatidylethanolamine* its manufacture and medicine containing same for lipemia and arteriosclerosis
IT1171432B (it) * 1981-08-03 1987-06-10 Fidia Farmaceutici Amidi organiche derivate da lipidi azotati utilizzabili come farmaci

Also Published As

Publication number Publication date
ES533004A0 (es) 1985-12-16
DK159204B (da) 1990-09-17
YU42914B (en) 1988-12-31
FI822672A0 (fi) 1982-07-30
FI75829B (fi) 1988-04-29
ES514683A0 (es) 1984-12-16
US4897382A (en) 1990-01-30
FI822672L (fi) 1983-02-04
YU73485A (en) 1986-02-28
GR76234B (es) 1984-08-04
NO161314B (no) 1989-04-24
YU168982A (en) 1986-02-28
NO822631L (no) 1983-02-04
IT8149031A0 (it) 1981-08-03
FI75829C (fi) 1988-08-08
HU192771B (en) 1987-07-28
DE3273983D1 (en) 1986-12-04
PL237756A1 (en) 1985-05-07
PT75363B (en) 1984-12-10
US4897381A (en) 1990-01-30
IE53644B1 (en) 1989-01-04
PL141417B1 (en) 1987-07-31
YU42913B (en) 1988-12-31
IE821863L (en) 1983-02-03
KR840001170A (ko) 1984-03-28
ES545241A0 (es) 1986-07-16
DK346282A (da) 1983-02-04
AU561811B2 (en) 1987-05-21
JPS5843942A (ja) 1983-03-14
YU43085B (en) 1989-02-28
EP0072286B1 (en) 1986-10-29
US4757053A (en) 1988-07-12
DK159204C (da) 1991-03-11
NZ201439A (en) 1986-02-21
JPH0558976A (ja) 1993-03-09
YU73585A (en) 1986-02-28
NO161314C (no) 1989-08-02
IT8149031A1 (it) 1983-02-03
IT1171432B (it) 1987-06-10
EP0072286A1 (en) 1983-02-16
ZA825585B (en) 1983-06-29
ES8602616A1 (es) 1985-12-16
PT75363A (en) 1982-09-01
IL66454A0 (en) 1982-12-31
AU8672682A (en) 1983-02-10
JPH0512329B2 (es) 1993-02-17
ES8501735A1 (es) 1984-12-16
ATE23165T1 (de) 1986-11-15
KR880000042B1 (ko) 1988-02-20
EP0072286B2 (en) 1992-12-09

Similar Documents

Publication Publication Date Title
ES8608480A1 (es) Procedimiento perfeccionado para la fabricacion de derivadosde amidas organicas de lipidos nitrogenados
ES8704949A1 (es) Procedimiento para preparar nuevas amidas de acidos tieno-triazolo-1,4-diazepino-2-carboxilicos
ES2125962T3 (es) Procedimiento de preparacion de monoesteres mayoritariamente en posicion 6' de la d-maltosa y su utilizacion en los campos cosmetico, bucodental, farmaceutico y alimenticio.
ES2159851T3 (es) Amidas de acidos aminotiofenocarboxilicos y su empleo como inhibidores de la fosfodiestearasa.
ES2038692T3 (es) Procedimiento para la obtencion de acidos alcanodifosfonicos substituidos.
MX168494B (es) Nuevos derivados de pirazolina su preparacion y su uso como plaguisidas
MX174142B (es) Procedimiento para la preparacion de nuevos esteroides y producto obtenido
ES2064371T3 (es) Procedimiento enzimatico para la produccion de cianhidrinas opticamente activas.
MX9306835A (es) Proceso continuo de una sola etapa, para la produccion de mezclasisomericas de dinitrotolueno.
ES8304070A1 (es) "procedimiento para la preparacion de nuevas amidas de acidos carboxilicos".
ES8706692A1 (es) Un metodo para preparar nuevos derivados de cefem
ES8801666A1 (es) Un procedimiento para la prepracion de derivados de acidos griseolicos.
MX9301126A (es) Fenilacetamidas sustituidas por imidazolilo, procedimiento para su obtencion y medicamentos que los contienen.
AR241477A1 (es) Procedimiento para la transformacion del componente 1 de la teicoplanina factor a2, componente 1 en teicoplanina factor a2 componente 3.
ID25870A (id) Zat thiksotropik berdasarkan resin alkid
ES2059919T3 (es) Amidas de acidos carboxilicos aromaticos, su obtencion y su utilizacion medicamentosa.
ES2046218T3 (es) Derivados de acidos piridin-2,4- y -2,5-dicarboxilicos, procedimientos para su produccion, aplicacion de los mismos asi como medicamentos a base de estos compuestos.
ES8405013A1 (es) Procedimiento para preparar derivados de tieno-tiazol
MX167392B (es) Procedimiento para preparar ni-metil-10 metoxilumilisergol
ES8503676A1 (es) Procedimiento de producir derivados de acido oxazolacetico
ES493223A0 (es) Procedimiento para la hidroxilacion de 3-cloro-2-metil-pro- peno,1,de monoolefinas o de diolefinas
ES2055089T3 (es) Procedimiento para preparar 4-metilpirazoles.
ES8707259A1 (es) Procedimiento para preparar derivados de aminoacidos
DE3263121D1 (en) Medicines containing an n-acyl-l-aspactyl-taurine
ES2035102T3 (es) Compuestos que contienen hierro biodisponible, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970401